Loading...
XHKG
1827
Market cap56mUSD
Nov 20, Last price  
1.10HKD
Name

Miricor Enterprises Holdings Ltd

Chart & Performance

D1W1MN
XHKG:1827 chart
P/E
41.55
P/S
1.09
EPS
0.03
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
17.96%
Revenues
403m
-18.43%
74,000,00083,352,000100,104,000127,213,000154,695,000176,529,000128,871,000363,915,000463,117,000494,260,000403,152,000
Net income
11m
P
13,495,00018,488,00059,00026,513,00021,798,00013,556,000-12,653,00025,382,000-20,501,000-12,616,00010,590,000
CFO
114m
+35.01%
32,022,0009,293,00043,302,000-14,258,00046,599,00063,505,00024,535,00044,029,00099,453,00084,451,000114,020,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong. It also offers a range of non-surgical medical aesthetic services, including energy-based and injection procedures. The company operates three medical aesthetic centers under the CosMax+ name. It also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, and masks. Miricor Enterprises Holdings Limited was founded in 2009 and is headquartered in Causeway Bay, Hong Kong.
IPO date
Jan 10, 2017
Employees
302
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT